Orestis A Panagiotou1, Amit Kumar2, Roee Gutman1, Laura M Keohane3, Maricruz Rivera-Hernandez1, Momotazur Rahman1, Pedro L Gozalo4, Vincent Mor4, Amal N Trivedi4. 1. Brown University School of Public Health, Providence, Rhode Island (O.A.P., R.G., M.R., M.R.). 2. College of Health & Human Services, Northern Arizona University, Flagstaff, Arizona (A.K.). 3. Vanderbilt University School of Medicine, Nashville, Tennessee (L.M.K.). 4. Brown University School of Public Health and Providence VA Medical Center, Providence, Rhode Island (P.L.G., V.M., A.N.T.).
Abstract
Background: Medicare's Hospital Readmissions Reduction Program reports risk-standardized readmission rates for traditional Medicare but not Medicare Advantage beneficiaries. Objective: To compare readmission rates between Medicare Advantage and traditional Medicare. Design: Retrospective cohort study linking the Medicare Provider Analysis and Review (MedPAR) file with the Healthcare Effectiveness Data and Information Set (HEDIS). Setting: 4748 U.S. acute care hospitals. Patients: Patients aged 65 years or older hospitalized for acute myocardial infarction (AMI) (n = 841 613), congestive heart failure (CHF) (n = 1 458 652), or pneumonia (n = 2 020 365) between 2011 and 2014. Measurements: 30-day readmissions. Results: Among admissions for AMI, CHF, and pneumonia identified in MedPAR, 29.2%, 38.0%, and 37.2%, respectively, did not have a corresponding record in HEDIS. Of these, 18.9% for AMI, 23.7% for CHF, and 18.3% for pneumonia resulted in a readmission that was identified in MedPAR. However, among index admissions appearing in HEDIS, 14.4% for AMI, 18.4% for CHF, and 13.9% for pneumonia resulted in a readmission. Patients in Medicare Advantage had lower unadjusted readmission rates than those in traditional Medicare for all 3 conditions (16.6% vs. 17.1% for AMI, 21.4% vs. 21.7% for CHF, and 16.3% vs. 16.4% for pneumonia). However, after standardization, patients in Medicare Advantage had higher readmission rates than patients in traditional Medicare for AMI (17.2% vs. 16.9%; difference, 0.3 percentage point [95% CI, 0.1 to 0.5 percentage point]), CHF (21.7% vs. 21.4%; difference, 0.3 percentage point [CI, 0.2 to 0.5 percentage point]), and pneumonia (16.5% vs. 16.0%; difference, 0.5 percentage point [95% CI, 0.4 to 0.6 percentage point]). Rate differences increased between 2011 and 2014. Limitation: Potential unobserved differences between populations. Conclusion: The HEDIS data underreported hospital admissions for 3 common medical conditions, and readmission rates were higher among patients with underreported admissions. Medicare Advantage beneficiaries had higher risk-adjusted 30-day readmission rates than traditional Medicare beneficiaries. Primary Funding Source: National Institute on Aging.
Background: Medicare's Hospital Readmissions Reduction Program reports risk-standardized readmission rates for traditional Medicare but not Medicare Advantage beneficiaries. Objective: To compare readmission rates between Medicare Advantage and traditional Medicare. Design: Retrospective cohort study linking the Medicare Provider Analysis and Review (MedPAR) file with the Healthcare Effectiveness Data and Information Set (HEDIS). Setting: 4748 U.S. acute care hospitals. Patients: Patients aged 65 years or older hospitalized for acute myocardial infarction (AMI) (n = 841 613), congestive heart failure (CHF) (n = 1 458 652), or pneumonia (n = 2 020 365) between 2011 and 2014. Measurements: 30-day readmissions. Results: Among admissions for AMI, CHF, and pneumonia identified in MedPAR, 29.2%, 38.0%, and 37.2%, respectively, did not have a corresponding record in HEDIS. Of these, 18.9% for AMI, 23.7% for CHF, and 18.3% for pneumonia resulted in a readmission that was identified in MedPAR. However, among index admissions appearing in HEDIS, 14.4% for AMI, 18.4% for CHF, and 13.9% for pneumonia resulted in a readmission. Patients in Medicare Advantage had lower unadjusted readmission rates than those in traditional Medicare for all 3 conditions (16.6% vs. 17.1% for AMI, 21.4% vs. 21.7% for CHF, and 16.3% vs. 16.4% for pneumonia). However, after standardization, patients in Medicare Advantage had higher readmission rates than patients in traditional Medicare for AMI (17.2% vs. 16.9%; difference, 0.3 percentage point [95% CI, 0.1 to 0.5 percentage point]), CHF (21.7% vs. 21.4%; difference, 0.3 percentage point [CI, 0.2 to 0.5 percentage point]), and pneumonia (16.5% vs. 16.0%; difference, 0.5 percentage point [95% CI, 0.4 to 0.6 percentage point]). Rate differences increased between 2011 and 2014. Limitation: Potential unobserved differences between populations. Conclusion: The HEDIS data underreported hospital admissions for 3 common medical conditions, and readmission rates were higher among patients with underreported admissions. Medicare Advantage beneficiaries had higher risk-adjusted 30-day readmission rates than traditional Medicare beneficiaries. Primary Funding Source: National Institute on Aging.
Authors: M E Gornick; P W Eggers; T W Reilly; R M Mentnech; L K Fitterman; L E Kucken; B C Vladeck Journal: N Engl J Med Date: 1996-09-12 Impact factor: 91.245
Authors: Amit Kumar; Momotazur Rahman; Amal N Trivedi; Linda Resnik; Pedro Gozalo; Vincent Mor Journal: PLoS Med Date: 2018-06-26 Impact factor: 11.069
Authors: Maricruz Rivera-Hernandez; Amilcar Matos-Moreno; Nasim B Ferdows; Amit Kumar Journal: J Am Med Dir Assoc Date: 2020-12-08 Impact factor: 4.669
Authors: Oanh Kieu Nguyen; Colin Washington; Christopher R Clark; Michael E Miller; Vivek A Patel; Ethan A Halm; Anil N Makam Journal: J Gen Intern Med Date: 2021-01-14 Impact factor: 6.473
Authors: Orestis A Panagiotou; Kirsten R Voorhies; Laura M Keohane; Daeho Kim; Deepak Adhikari; Amit Kumar; Maricruz Rivera-Hernandez; Momotazur Rahman; Pedro Gozalo; Roee Gutman; Vincent Mor; Amal N Trivedi Journal: JAMA Netw Open Date: 2021-02-01